Vimarsana
Biggest News Aggregation in the World

Daventry Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daventry Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daventry Group Today - Breaking & Trending Today

Health Care Adviser Marwood Renews 19K-SF Lease at 733 Third Avenue - Vimarsana News

Health Care Adviser Marwood Renews 19K-SF Lease at 733 Third Avenue

Health care advisory firm Marwood Group renews 19,000 square feet at 733 Third Avenue.

North Growth Management Ltd. Boosts Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL) - Vimarsana News

North Growth Management Ltd. Boosts Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)

North Growth Management Ltd. lifted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 15.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 37,000 shares of the medical research company’s stock after purchasing an additional 5,000 shares during the […]

Source: wkrb13.com
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by Brokerages - Vimarsana News

Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by Brokerages

Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) has earned an average rating of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among […]

Source: wkrb13.com
Cornerstone Investment Partners LLC Makes New Investment in Health Catalyst, Inc. (NASDAQ:HCAT) - Vimarsana News

Cornerstone Investment Partners LLC Makes New Investment in Health Catalyst, Inc. (NASDAQ:HCAT)

Cornerstone Investment Partners LLC bought a new position in shares of Health Catalyst, Inc. (NASDAQ:HCAT – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 13,552 shares of the company’s stock, valued at approximately $169,000. Other institutional investors also recently bought and […]

Health Catalyst (NASDAQ:HCAT) Rating Reiterated by Cantor Fitzgerald - Vimarsana News

Health Catalyst (NASDAQ:HCAT) Rating Reiterated by Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $16.00 target price on the stock. Separately, Canaccord Genuity Group reduced their price target on shares of Health Catalyst from $16.00 to $14.00 and […]